This is the authors' abstract. We don't add key points for this paper.
cells of β-thalassemic individuals. Our findings define a drug-regulatable pathway for ameliorating β-thalassemia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lechauve et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: